Mark Cynthia, Pujara Vivek, Boyle Marissa K, Yuan Yuan, Lee Jin Sun
Division of Medical Oncology, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, 8700 Beverly Blvd., Los Angeles, CA, 90048, USA.
Division of Surgical Oncology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Breast Cancer Res Treat. 2025 Apr;210(3):521-528. doi: 10.1007/s10549-024-07588-0. Epub 2025 Jan 5.
There is an increasing incidence of young breast cancer (YBC) patients with uncertainty surrounding the factors and patterns that are contributing.
We obtained characteristics and survival data from 206,156 YBC patients (≤ 40 years of age) diagnosed between 2005 and 2019 from the National Cancer Database (NCDB). Patients were subdivided into two comparison groups based on year of diagnosis (2005-2009, Old vs. 2015-2019, New group). A Chi-square test of independence was employed to measure the changes. Cox proportional hazards model was used to explore the variables influencing overall survival (OS).
Comparison between Old (55,397 patients) and New groups (67,930 patients) showed an increase in the proportion of Hispanic (8.4% vs 10.0%), Black (16.0% vs 16.6%), and Asian (4.8% vs 6.7%) populations. In the New group, black patients had a significantly worse OS, p < 0.001. Additionally, there was a reduction in the proportion of patients with private insurance (43,940 (81.7%) vs 51,104 (76.4%)) and an increase in patients with Medicaid (5,893 (11.0%) vs 10,694 (16.0%)). Finally, there was a significant increase in hormone positive disease (35,142 (70.0%) vs 49,409 (75.8%), p = < 0.001).
Within YBC patients, the proportion of underrepresented and underserved population is increasing, with an impact on OS. We also see an increase in hormone positive disease. Awareness of these at-risk populations is important for early identification of breast cancer and mitigation of poorer outcomes. Also, there are increasing rates of hormone positive disease which can cause substantial personal and societal implications, such as impacts on family planning and early menopause.
年轻乳腺癌(YBC)患者的发病率不断上升,但其相关影响因素和模式尚不明确。
我们从国家癌症数据库(NCDB)中获取了2005年至2019年间诊断出的206,156例YBC患者(年龄≤40岁)的特征和生存数据。根据诊断年份将患者分为两个比较组(2005 - 2009年,旧组对比2015 - 2019年,新组)。采用卡方独立性检验来衡量变化情况。使用Cox比例风险模型探索影响总生存期(OS)的变量。
旧组(55,397例患者)和新组(67,930例患者)比较显示,西班牙裔(8.4%对10.0%)、黑人(16.0%对16.6%)和亚洲人(4.8%对6.7%)人群的比例有所增加。在新组中,黑人患者的OS明显更差,p < 0.001。此外,拥有私人保险的患者比例有所下降(43,940例(81.7%)对51,104例(76.4%)),而医疗补助患者比例有所增加(5,893例(11.0%)对10,694例(16.0%))。最后,激素受体阳性疾病显著增加(35,142例(70.0%)对49,409例(75.8%),p = < 0.001)。
在YBC患者中,代表性不足和服务不足人群的比例在增加,这对OS有影响。我们还发现激素受体阳性疾病有所增加。了解这些高危人群对于早期发现乳腺癌和改善较差的预后很重要。此外,激素受体阳性疾病的发病率不断上升,这可能会对个人和社会产生重大影响,如对计划生育和早期绝经的影响。